15°C New York
February 21, 2024
The pipeline and market for psoriasis drugs
Trending Now

The pipeline and market for psoriasis drugs

Feb 20, 2024


Psoriasis is a chronic T-lymphocyte-mediated inflammatory disorder that affects 2–3% of the population globally. It is associated with abnormal keratinocyte proliferation, and is clinically characterized by erythematous, clearly demarcated papules and rounded plaques. Approximately 75% of patients with psoriasis will have at least one comorbid condition, with psoriatic arthritis being the most common.

Competing Interests

The authors declare no competing interests.



Source link